BGB-B455 / BeOne Medicines - LARVOL DELTA

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - P1 | N=80 | Not yet recruiting | Sponsor: BeiGene

New P1 trial • Oncology • Solid Tumor

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - P1 | N=90 | Recruiting | Sponsor: BeOne Medicines | Trial completion date: Oct 2027 ➔ Apr 2028 | Trial primary completion date: Oct 2027 ➔ Apr 2028

Trial completion date • Trial primary completion date • Oncology • Ovarian Cancer • Solid Tumor • CLDN6

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - P1 | N=80 | Recruiting | Sponsor: BeiGene | Not yet recruiting ➔ Recruiting

Enrollment open • Oncology • Solid Tumor